Active targeting of nanotherapeutics using power cavitation imaging with a linear array transducer

Abstract

Power cavitation imaging (PCI) is an emerging strategy for monitoring blood–brain barrier (BBB) opening, enabling spatial discrimination of cavitation intensity through power Doppler-analogous processing of passive cavitation images. Single-element cavitation detectors, while beneficial in signal monitoring for cavitation controllers, provide limited spatial information, conferring the need for an image-guided approach to ensure accurate cavitation localization and regulation. This study aims to evaluate the capability of PCI to spatially correlate real-time acoustic cavitation emissions with mechanical bioeffects as a predictor of P-selectin-targeted nanocarrier delivery. Preliminary sonoporation experiments were performed in vitro with brain tissue derived mouse endothelial cells and 3 kDa tetramethylrhodamine (TMR)-dextran. A focused ultrasound transducer (0.5 MHz, 5000 cycles/pulse, 5 Hz PRF, 30 second treatment duration) was used to sonicate cells in small volume (25 μl) cell suspension. Homogenous distribution of TMR-dextran in the cytosol and nucleus was observed via fluorescence microscopy at lower pressures (7% ± 2% fluorescent cells), while higher pressures had no significant differences above control (3% ± 2% vs 1% nontreated) due to microbubble destruction. Future experiments will correlate sonoporation with P-selectin expression and validate a linear array PCI system against contrast-enhanced MRI as a guide for P-selectin-targeted nanocarrier delivery in mouse models of medulloblastoma.